These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

97 related articles for article (PubMed ID: 16670319)

  • 1. Defective adhesion in tumor infiltrating CD8+ T cells.
    Koneru M; Monu N; Schaer D; Barletta J; Frey AB
    J Immunol; 2006 May; 176(10):6103-11. PubMed ID: 16670319
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Suppression of proximal T cell receptor signaling and lytic function in CD8+ tumor-infiltrating T cells.
    Monu N; Frey AB
    Cancer Res; 2007 Dec; 67(23):11447-54. PubMed ID: 18056473
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Defective proximal TCR signaling inhibits CD8+ tumor-infiltrating lymphocyte lytic function.
    Koneru M; Schaer D; Monu N; Ayala A; Frey AB
    J Immunol; 2005 Feb; 174(4):1830-40. PubMed ID: 15699109
    [TBL] [Abstract][Full Text] [Related]  

  • 4. CD8(+) tumor-infiltrating T cells are deficient in perforin-mediated cytolytic activity due to defective microtubule-organizing center mobilization and lytic granule exocytosis.
    Radoja S; Saio M; Schaer D; Koneru M; Vukmanovic S; Frey AB
    J Immunol; 2001 Nov; 167(9):5042-51. PubMed ID: 11673513
    [TBL] [Abstract][Full Text] [Related]  

  • 5. CD8+ tumor-infiltrating lymphocytes are primed for Fas-mediated activation-induced cell death but are not apoptotic in situ.
    Radoja S; Saio M; Frey AB
    J Immunol; 2001 May; 166(10):6074-83. PubMed ID: 11342625
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The Inhibitory Signaling Receptor Protocadherin-18 Regulates Tumor-Infiltrating CD8
    Frey AB
    Cancer Immunol Res; 2017 Oct; 5(10):920-928. PubMed ID: 28874354
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Treatment-enhanced CD4+Foxp3+ glucocorticoid-induced TNF receptor family related high regulatory tumor-infiltrating T cells limit the effectiveness of cytokine-based immunotherapy.
    Berhanu A; Huang J; Watkins SC; Okada H; Storkus WJ
    J Immunol; 2007 Mar; 178(6):3400-8. PubMed ID: 17339434
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Defective CD8+ T cell activation and cytolytic function in the absence of LFA-1 cannot be restored by increased TCR signaling.
    Shier P; Ngo K; Fung-Leung WP
    J Immunol; 1999 Nov; 163(9):4826-32. PubMed ID: 10528183
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Characterization of defective CD4-CD8- T cells in murine tumors generated independent of antigen specificity.
    Prins RM; Incardona F; Lau R; Lee P; Claus S; Zhang W; Black KL; Wheeler CJ
    J Immunol; 2004 Feb; 172(3):1602-11. PubMed ID: 14734741
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Reconstitution of CD8+ T cells by retroviral transfer of the TCR alpha beta-chain genes isolated from a clonally expanded P815-infiltrating lymphocyte.
    Tahara H; Fujio K; Araki Y; Setoguchi K; Misaki Y; Kitamura T; Yamamoto K
    J Immunol; 2003 Aug; 171(4):2154-60. PubMed ID: 12902522
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Interleukin-2 activated microglia engulf tumor infiltrating T cells in the central nervous system.
    Tamakawa N; Saio M; Suwa T; Ohe N; Yoshimura S; Iwama T; Shinoda J; Sakai N; Takami T
    Int J Mol Med; 2004 Apr; 13(4):497-503. PubMed ID: 15010848
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Different expression of Fas and Fas ligand in tumor infiltrating and peripheral lymphocytes of patients with renal cell carcinomas.
    Elsässer-Beile U; Gierschner D; Welchner T; Wetterauer U
    Anticancer Res; 2003; 23(1A):433-7. PubMed ID: 12680244
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Role of adhesion molecules in the immune reaction to M-MSV-induced tumors.
    Rosato A; Bronte V; Mandruzzato S; Zambon A; Calderazzo F; Biasi G; Zanovello P; Collavo D
    Int J Cancer Suppl; 1992; 7():24-7. PubMed ID: 1385341
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Phenotypic characterization of murine tumor-infiltrating T lymphocytes.
    Karpati RM; Banks SM; Malissen B; Rosenberg SA; Sheard MA; Weber JS; Hodes RJ
    J Immunol; 1991 Mar; 146(6):2043-51. PubMed ID: 1672340
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Protocadherin-18 is a novel differentiation marker and an inhibitory signaling receptor for CD8+ effector memory T cells.
    Vazquez-Cintron EJ; Monu NR; Burns JC; Blum R; Chen G; Lopez P; Ma J; Radoja S; Frey AB
    PLoS One; 2012; 7(5):e36101. PubMed ID: 22567129
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Successful adoptive cellular immunotherapy is dependent on induction of a host immune response triggered by cytokine (IFN-gamma and granulocyte/macrophage colony-stimulating factor) producing donor tumor-infiltrating lymphocytes.
    Nagoshi M; Goedegebuure PS; Burger UL; Sadanaga N; Chang MP; Eberlein TJ
    J Immunol; 1998 Jan; 160(1):334-44. PubMed ID: 9551989
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Slow cluster formation of purified human or rhesus T cells requires protein kinase C and LFA-1.
    Eylar EH; Molina C; Báez I; Kessler M
    P R Health Sci J; 1996 Mar; 15(1):13-9. PubMed ID: 8744862
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Loss of B7.2 (CD86) and intracellular adhesion molecule 1 (CD54) expression is associated with decreased tumor-infiltrating T lymphocytes in diffuse B-cell large-cell lymphoma.
    Stopeck AT; Gessner A; Miller TP; Hersh EM; Johnson CS; Cui H; Frutiger Y; Grogan TM
    Clin Cancer Res; 2000 Oct; 6(10):3904-9. PubMed ID: 11051236
    [TBL] [Abstract][Full Text] [Related]  

  • 19. T cells infiltrating non-Hodgkin's B cell lymphomas show altered tyrosine phosphorylation pattern even though T cell receptor/CD3-associated kinases are present.
    Wang Q; Stanley J; Kudoh S; Myles J; Kolenko V; Yi T; Tubbs R; Bukowski R; Finke J
    J Immunol; 1995 Aug; 155(3):1382-92. PubMed ID: 7636203
    [TBL] [Abstract][Full Text] [Related]  

  • 20. CD20+ tumor-infiltrating lymphocytes have an atypical CD27- memory phenotype and together with CD8+ T cells promote favorable prognosis in ovarian cancer.
    Nielsen JS; Sahota RA; Milne K; Kost SE; Nesslinger NJ; Watson PH; Nelson BH
    Clin Cancer Res; 2012 Jun; 18(12):3281-92. PubMed ID: 22553348
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.